The dye, a compound called orcein, and the related substance O4, bind preferentially to small amyloid aggregates that are considered to be toxic and cause neuronal dysfunction and memory impairment in Alzheimer’s disease. O4 binding to small aggregates promotes their conversion into large, mature plaques which researchers from the Max Delbrück Center (MDC) and the Charité – Universitätsmedizin Berlin in Germany assume to be largely non-toxic for neuronal cells (Nature Chemical Biology, doi: http://dx.doi.org/10.1038/NCHEMBIO.719)*.
Further research with animal models is needed to determine whether this new approach by Dr. Jan Bieschke (MDC), Dr. Martin Herbst (Charité) and Professor Erich Wanker (MDC) will be useful for therapy development.
Protein misfolding is considered to be the cause of Alzheimer’s, Parkinson’s and also Huntington’s disease. In a multistep process, proteins misfold and accumulate into large extra- or intracellular plaques. Researchers assume that small misfolded protein aggregates that are precursors of mature plaques are toxic for nerve cells and are the reason why they are eventually destroyed.
“This is a new mechanism,” Professor Wanker explained. “Up to now it has been considered to be very difficult to stop the formation of small toxic protein assemblies. If our hypothesis is correct that the small aggregates, which are precursors of plaques, indeed cause neuronal death, with O4 we would have a new mechanism to attack the disease.”
The synthetic dye methylene blue is currently being tested in clinical trials. This dye also seems to stimulate the formation of large plaques in a way similar to O4. Other therapeutic approaches tested in clinical trials which aim at eliminating small precursor aggregates have so far not led to a significant improvement of disease symptoms.
However, it still remains to be seen whether the blue dye O4 can also be effective against small amounts of misfolded proteins in the brains of Alzheimer’s patients and whether the accelerated formation of larger plaques can indeed reduce the signs and symptoms of Alzheimer’s disease in humans. Further studies will be necessary to address the question whether the accelerated formation of large plaques can be a therapeutic approach. “We hope that our findings will stimulate research activities in this direction, especially in drug discovery,” Professor Wanker said.*Small-molecule conversion of toxic oligomers to nontoxic b-sheet–rich amyloid fibrils
Jan Bieschke1,12, Martin Herbst1,2,12, Thomas Wiglenda1, Ralf PFriedrich1, Annett Boeddrich1, Franziska Schiele1, Daniela Kleckers1, Juan Miguel Lopez del Amo3, Björn Grüning4, Qinwen Wang5,11, Michael RSchmidt1, Rudi Lurz6, Roger Anwyl5, Sigrid Schnoegl1, Marcus Fändrich7, Ronald F Frank8, Bernd Reif3,9, Stefan Günther4, Dominic M Walsh10 & Erich EWanker1
1Neuroproteomics, Max Delbrück Center for Molecular Medicine, Berlin, Germany. 2Department of Neurology, Charité-Universitätsmedizin Berlin, Germany. 3Leibniz Institute for Molecular Pharmacology, Berlin, Germany. 4Institute for Pharmaceutical Sciences, University of Freiburg, Germany. 5Department of Physiology, School of Medicine, Trinity College, Dublin, Republic of Ireland, 6Max Planck Institute for Molecular Genetics, Berlin, Germany. 7Max Planck Research Unit for Enzymology of Protein Folding, Halle (Saale), Germany. 8Department of Chemistry, Helmholtz Center for Infection Research, Braunschweig, Germany. 9Technical University Munich, Munich, Germany. 10Laboratory for Neurodegenerative Research, The Conway Institute for Biomolecular and Biomedical Research, University College Dublin, Republic of Ireland. 11Present address: Department of Physiology and Pharmacology, Medical School, Ningbo University, Ningbo, China. 12These authors contributed equally to this work.Barbara Bachtler
Barbara Bachtler | Max-Delbrück-Centrum
X-ray scattering shines light on protein folding
10.07.2020 | The Korea Advanced Institute of Science and Technology (KAIST)
Surprisingly many peculiar long introns found in brain genes
10.07.2020 | Moscow Institute of Physics and Technology
New insight into the spin behavior in an exotic state of matter puts us closer to next-generation spintronic devices
Aside from the deep understanding of the natural world that quantum physics theory offers, scientists worldwide are working tirelessly to bring forth a...
Kiel physics team observed extremely fast electronic changes in real time in a special material class
In physics, they are currently the subject of intensive research; in electronics, they could enable completely new functions. So-called topological materials...
Solar cells based on perovskite compounds could soon make electricity generation from sunlight even more efficient and cheaper. The laboratory efficiency of these perovskite solar cells already exceeds that of the well-known silicon solar cells. An international team led by Stefan Weber from the Max Planck Institute for Polymer Research (MPI-P) in Mainz has found microscopic structures in perovskite crystals that can guide the charge transport in the solar cell. Clever alignment of these "electron highways" could make perovskite solar cells even more powerful.
Solar cells convert sunlight into electricity. During this process, the electrons of the material inside the cell absorb the energy of the light....
Empa researchers have succeeded in applying aerogels to microelectronics: Aerogels based on cellulose nanofibers can effectively shield electromagnetic radiation over a wide frequency range – and they are unrivalled in terms of weight.
Electric motors and electronic devices generate electromagnetic fields that sometimes have to be shielded in order not to affect neighboring electronic...
A promising operating mode for the plasma of a future power plant has been developed at the ASDEX Upgrade fusion device at Max Planck Institute for Plasma...
07.07.2020 | Event News
02.07.2020 | Event News
19.05.2020 | Event News
10.07.2020 | Life Sciences
10.07.2020 | Materials Sciences
10.07.2020 | Life Sciences